Proteoglycan metabolism of equine articular cartilage and its modulation by insulin-like growth factors.

The research investigated the impact of a specific growth factor (rhIGF-1) on the production and breakdown of proteoglycans, a key component of cartilage, in horse joints.

Objective and Method

• This study explored the effect of the human recombinant insulin-like growth factor 1 (rhIGF-1) on the metabolism of proteoglycans (PGs)—important proteins present in cartilage—in horse articular cartilage samples of varying ages.
• The method involved administering different levels of rhIGF-1 to the cartilage samples and subsequently analyzing the changes in proteoglycan synthesis and turnover.

Findings

• The research found that rhIGF-1 significantly influenced PG synthesis in these cartilage samples, stimulating its production across all age sets, albeit at varying intensities.
• However, adult cartilage samples required higher concentrations of rhIGF-1 for maximal stimulation of PG synthesis.
• Interestingly, the proteoglycans produced after rhIGF-1 stimulation showed no changes in their hydrodynamic size, electrophoretic heterogeneity, or composition—a finding that indicates the growth factor’s primarily role in promoting synthesis rather than altering proteoglycan character.

Implications

• Apart from promoting PG synthesis, rhIGF-1 was found to slow down proteoglycan turnover, implying an overall modulating effect on the equilibrium of proteoglycan production and breakdown.
• This effect on turnover rates was consistent across all cartilage ages studied.
• Importantly, IGF-1 does not disrupt the structure of proteoglycan fragments whether retained in the matrix or released into the culture medium. Researchers thus concluded that rhIGF-1 plays a crucial role in stabilizing the composition of proteoglycans in the extracellular matrix of horse joint cartilage, thereby suggesting its potential therapeutic use in treating cartilage-related issues in equines.